Internal Medicine, Cardiovascular Disease · Greenville, SC
NPI
1386871093
Since 2009
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
2 Innovation Dr,. Ste 400
Greenville, SC, 29607
Phone (864) 235-7665
Groups this clinician bills Medicare through
Medicare paid, 2024
$288K
5,870 services
Medicare patients, 2024
1,827
Average age 77
Drug cost, 2024
$2.4M
11,293 prescriptions
Company payments, 2025
$375
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James A Merriam Jr. was code 99214 (office e&m - established), 1,649 times for 856 patients. In total James A Merriam Jr. billed 5,870 services in 53 codes, and Medicare paid $288K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,649 | 856 | $81.69 | $135K |
| 93000 Electrocardiogram | Office | 641 | 606 | $9.01 | $5,777 |
| 93010 Electrocardiogram | Facility | 580 | 515 | $5.48 | $3,179 |
| 93793 Care Management/Coordination | Office | 416 | 36 | $7.18 | $2,987 |
| 85610 Clinical Chemistry | Office | 288 | 28 | $4.20 | $1,210 |
| 93306 Echocardiography (TTE/TEE) | Office | 275 | 274 | $134.24 | $37K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 268 | 66 | $5.80 | $1,555 |
| 93298 External Electrocardiographic Monitoring | Office | 235 | 35 | $43.76 | $10K |
| 93294 External Electrocardiographic Monitoring | Office | 231 | 83 | $19.91 | $4,599 |
| 93296 External Electrocardiographic Monitoring | Office | 231 | 83 | $13.79 | $3,185 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 184 | 91 | $85.59 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 96 | 63 | $58.52 | $5,618 |
| 93015 Electrocardiogram | Office | 92 | 91 | $46.28 | $4,257 |
| 78452 Myocardial Perfusion Scan | Office | 92 | 91 | $302.39 | $28K |
| Q9957 Injection, perflutren lipid microspheres, per ml | Office | 88 | 44 | $33.15 | $2,917 |
By year: 2022 $288K for 5,300 services; 2023 $340K for 6,243 services; 2024 $288K for 5,870 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 288 | 28 | $4.20 | $1,210 |
Medicare prescription drug claims, 2024
In 2024, the drug James A Merriam Jr. prescribed most often to Medicare patients was Eliquis (Apixaban), with 834 prescriptions and refills. In total James A Merriam Jr. wrote 11,293 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 834 | 1,553 | 208 | $875K |
| Metoprolol Succinate Generic | 817 | 2,304 | 288 | $10K |
| Atorvastatin Calcium Generic | 749 | 2,165 | 244 | $6,670 |
| Amlodipine Besylate Generic | 522 | 1,447 | 184 | $2,836 |
| Nitroglycerin Generic | 432 | 455 | 263 | $4,044 |
| Carvedilol Generic | 424 | 1,156 | 132 | $3,309 |
| Furosemide Generic | 398 | 1,059 | 155 | $1,581 |
| Losartan Potassium Generic | 375 | 1,075 | 132 | $3,647 |
| Metoprolol Tartrate Generic | 371 | 1,009 | 124 | $2,315 |
| Spironolactone Generic | 353 | 963 | 133 | $2,608 |
| Lisinopril Generic | 340 | 978 | 119 | $1,856 |
| Repatha Sureclick Evolocumab | 240 | 300 | 42 | $161K |
| Rosuvastatin Calcium Generic | 240 | 677 | 83 | $3,797 |
| Clopidogrel Clopidogrel Bisulfate | 226 | 622 | 85 | $1,557 |
| Xarelto Rivaroxaban | 218 | 407 | 59 | $220K |
Brand drugs: - claims; generic drugs: 8,844 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James A Merriam Jr. $375 ($375 in general payments such as food, travel and fees) from 12 companies. The largest payer was Pfizer Inc. with $65.37.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 3 | $65.37 |
| Abiomed JNJ | 1 | $45.72 |
| Novo Nordisk Inc NVO | 2 | $41.91 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $39.6 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $31.67 |
| Abbott Laboratories ABT | 1 | $28.31 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $27.5 |
| Amgen Inc. AMGN | 1 | $23.76 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $19.64 |
| BridgeBio Pharma, Inc. BBIO | 1 | $19.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.